Human Fanconi anemia complementation group L. HGNC:20748. Synonym PHF9. 375 aa.
FANCL is the catalytic RING-type E3 ubiquitin ligase subunit of the multiprotein
Fanconi anemia (FA) core complex. Working with the dedicated E2 conjugating enzyme
UBE2T, FANCL monoubiquitinates FANCD2 (on Lys561) and FANCI (on Lys523), the key
activating step of the FA/interstrand-crosslink (ICL) repair pathway. The
monoubiquitinated FANCD2–FANCI (ID2) complex is recruited to chromatin at stalled
replication forks / ICLs and coordinates nucleolytic incision, translesion synthesis
and homologous recombination.
Domain architecture (UniProt Q9NW38): N-terminal E2-like/ELF (UBC-like) domain,
central "DRWD"/RWD-like domain, and a C-terminal RING-type zinc finger (residues
307–363, degenerate, binds 2 Zn). The UBC-RWD region (URD, ~104–294) mediates
interaction with FANCI and FANCD2; the RING binds the E2 (UBE2T). Cys307 is essential
for ligase activity (C307A abolishes activity). Trp341 is required for UBE2T binding.
Note the UniProt CAUTION: originally reported as a PHD-type zinc finger (PubMed:12724401)
but it is actually a RING-type zinc finger; PHD fingers have no ubiquitin ligase activity.
E3 ubiquitin ligase activity; essential for FANCD2 monoubiquitination:
PMID:12973351. Also defines involvement in FA (disease), catalytic activity, and C307/C310 mutagenesis abolishing activity.
UBE2T is the cognate E2 that binds FANCL (E2/E3 pair):
PMID:16916645. W341G abolishes UBE2T binding and ligase activity.
E3 activity determined by chromatin localization, forms active E2/E3 holoenzyme on chromatin:
PMID:17938197;
PMID:17938197.
Minimal reconstitution: Ube2t + FANCL monoubiquitinate FANCD2, stimulated by RWD-like domain; FANCI restricts site-specificity:
PMID:19111657;
PMID:19111657.
FANCL also monoubiquitinates FANCI (Lys523):
PMID:19589784.
Structure of FANCL RING–Ube2T; specific E3–E2 selection:
PMID:24389026;
PMID:24389026.
FA nuclear core complex membership / chromatin:
PMID:22343915.
PMID:20347428.
UniProt SUBUNIT: FA complex composed of FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCL/PHF9 and FANCM.
ICL repair pathway (downstream of FANCD2/FANCI monoubiquitination):
PMID:19965384.
ubiquitin protein ligase activity (GO:0061630): core, ACCEPT (IBA/IEA/EXP/IDA).ubiquitin-protein transferase activity (GO:0004842): parent of 0061630; correct but moreprotein monoubiquitination (GO:0006513): core, ACCEPT.interstrand cross-link repair (GO:0036297): core pathway, ACCEPT.Fanconi anaemia nuclear complex (GO:0043240): core location/complex, ACCEPT.chromatin (GO:0000785): site of active E3 holoenzyme, ACCEPT.protein binding (GO:0005515): uninformative; MARK_AS_OVER_ANNOTATED. Most areubiquitin protein ligase binding (GO:0031625, IPI with UBE2T/UBE2W which are E2s):ubiquitin conjugating enzyme binding (verified QuickGO/AmiGO:DNA repair (GO:0006281), DNA damage response (GO:0006974), protein ubiquitinationubiquitin binding (GO:0043130): NEW (not in GOA). ELF (E2-like fold) domain bindsAffinage record (run 2026-06-09, 22 discoveries, self-eval win) is a PMID-dense narrative
fully consistent with AIGR on the core biology. Its mechanism_profile GO layer is coarse
(GO:0016874 ligase activity, GO:0140096 catalytic activity acting on protein, GO:0031386
protein tag activity; nucleus/nuclear chromosome/mitochondrion) — do not import directly;
AIGR's GO:0061630 + GO:0031624 + specific locations are more precise. Incorporated
PMID:26149689 (ELF ubiquitin binding, above) as the one genuine MF the review lacked.
Affinage's moonlighting claims — K11-linked β-catenin/Wnt (PMID:22653977), ligase-independent
Parkin mitophagy (PMID:35644338), germ-cell/reproduction phenotypes (PMID:12417526,
PMID:20661450) — are single-study and/or non-human organism/tissue phenotypes; AIGR correctly
scopes them out of the human GO core-function set. Not added as annotations.